Gamow Labs is a company headquartered in the United States.
Gamow Labs develops an AI-native genomic interpretation platform that converts whole genome sequencing and patient phenotypes into auditable clinical reports for improved diagnosis and treatment planning.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.